申请人:——
公开号:US20040147470A1
公开(公告)日:2004-07-29
The present invention provides modified oligomeric compounds that modulate gene expression via an RNA interference pathway. The oligomeric compounds of the invention include one or more cross-linkages that can improve nuclease resistance or modify or enhance the pharmacokinetic and phamacodynamic properties of the oligomeric compound.
本发明提供了通过 RNA 干扰途径调节基因表达的改性低聚化合物。本发明的低聚化合物包括一种或多种交联,可提高核酸酶抗性或改变或增强低聚化合物的药代动力学和药效学特性。